ACN Newswire
Read More

Olympus Acquires Veran Medical Technologies, Inc.

indie
5 minutes

TOKYO, JP & CENTER VALLEY, PA, Dec 6, 2020 - (ACN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT) (CEO: Jason Pesterfield), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA), and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.As part of Olympus' Corporate Strategy, unveiled in November 2019, the company vowed to "focus and scale" its therapeutic solutions division. To accelerate the process and provide greater agility, Olympus made OCA the company's therapeutic division headquarters, recognizing the significant growth opportunities in North America. The company also identified three core medical fields to prioritize - gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.According ...

JCN Newswire
Read More

Olympus Grows Respiratory Portfolio with Acquisition of Veran Medical Technologies, Inc.

ruth
5 minutes

TOKYO, JP & CENTER VALLEY, PA, Dec 4, 2020 - (JCN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. ("VMT")(CEO: Jason Pesterfield), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas ("OCA"), and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.As part of Olympus' Corporate Strategy, unveiled in November 2019, the company vowed to "focus and scale" its therapeutic solutions division. To accelerate the process and provide greater agility, Olympus made OCA the company's therapeutic division headquarters, recognizing the significant growth opportunities in North America. The company also identified three core medical fields to prioritize - gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.Accordi...

ACN Newswire
Read More

TAITRA Launches 2020 Online Medical Show

indie
2 minutes

TAIPEI, TW, Dec 2, 2020 - (ACN Newswire) - Taiwan External Trade Development Council (TAITRA), the operator of the nation's largest B2B portal Taiwantrade.com, has launched the 2020 Online Medical Show.The dedicated online showcase houses 700 medical products from 28 leading medical suppliers. A creation of such online exhibition, TAITRA believes, not only will make a contribution to the global medical and healthcare industries during the pandemic, but will help Taiwan's suppliers gain enormous publicity. In meeting global demands for pandemic prevention, TAITRA also created the Anti-epidemic and Stay-at-home Economy online showcases, which cover 20,000 products from 15 industries.Taiwantrade.com, the largest B2B portal in Taiwan with an annual traffic of 32.5 million visitors, is sponsored by the Bureau of Foreign Trade and organized by TAITRA. In February, inquiries from worldwide buyers on the website grew 170% compared to the previous month.According to TAITRA Digital Commerce Department Director Chen Ling-chun, the pandemic led to a drastic increase in the number of inquiries for healthcare products on the website. Inquires for stay-at-home products also rose sharply due to th...

JCN Newswire
Read More

Fujitsu Rolls Out New Online Medical Solution to Drive Digital Transformation in Hospitals and Clinics

ruth
5 minutes

TOKYO, Nov 25, 2020 - (JCN Newswire) - Fujitsu today announced the commercial debut of its "FUJITSU Healthcare Solution Online Healthcare Solution" in the Japanese market, offering medical providers a powerful new tool to support COVID-19 countermeasures in medical frontlines and promote the digital transformation of doctors' work in hospitals and other medical institutions. The new solution connects all of Fujitsu's electronic medical record systems, ranging from those for small clinics to larger hospitals, with availability in Japan commencing on November 25, 2020. New solution in useThe offering will securely link with Fujitsu's HOPE LifeMark-Concierge application; available since 2016, which allows patients to make appointments and payments using a smartphone, while enabling safe and secure online medical examinations by letting patients access the URL of a video calling system used for online diagnosis through smartphone notifications. The solution empowers patients by allowing them to not only easily access online medical resources, but also manage everything from their appointments to billing with a smartphone app. By the end of fiscal 2020, Fujitsu plans to enhance its onli...

JCN Newswire
Read More

Olympus announces acquisition of FH ORTHO, an international orthopedics company in France

ruth
4 minutes

Tokyo/Hamburg, Nov 2, 2020 - (JCN Newswire) - Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has acquired FH ORTHO SAS, an international orthopedic company headquartered in Heimsbrunn, France, following the close of a definitive agreement the two companies signed in the summer of 2020. The acquisition underscores Olympus' commitment to expanding in the growing field of orthopedic minimally invasive surgery (MIS) both organically and through mergers and acquisitions, with the overarching goal of developing innovative solutions that improve clinical outcomes, reduce overall costs and enhance quality of life for patients.By acquiring FH ORTHO, Olympus builds on its portfolio of innovative and patient-focused solutions that are used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.Olympus is already active in orthopedics in Japan, where its joint venture Olympus Terumo Biomaterials Corp. distributes products such as bone substitutes and high tibial osteotomy (HTO) plates and screws. Beyond this, Olympus has also developed the first ultrasound device indicated for arthroscopic surgery,...

ACN Newswire
Read More

堃博C轮融资数千万美元 持续领跑肺部疾病精准介入治疗领域

judith
1 minute

HONG KONG, Oct 14, 2020 - (亚太商讯) - 肺部疾病精准介入治疗技术引领者堃博（Broncus）公司日前宣布，已完成数千万美元的C轮融资。本轮融资由清池资本领投，百度资本、济时资本、信银投资、德弘资本、启明创投跟投。本轮融资所得将主要用于巩固和扩张堃博旗下肺部疾病诊疗核心产品线，加速新产品的研发、临床研究、注册审批以及多元化的全球市场布局，帮助堃博持续领跑肺部疾病精准介入治疗领域。堃博此前获得启明创投、Intuitive Surgical等全球知名风险投资机构以及产业巨擘的持续投资。肺癌、慢阻肺患者人群巨大，疾病危害严重。以肺癌为例，肺癌是全球范围内发病率和死亡率最高的恶性肿瘤，世界卫生组织（WHO）在2018年发布的全球癌症报告中指出，肺癌是2018年全球发病率最高的癌症，占到当年新发癌症总病例数量的11.6%。仅在中国就约有1亿肺小结节携带者，每年新发肺癌患者近80万例，其中70-80%患者在发现肺癌时已属晚期。早期肺癌的五年生存率约为90%，6倍于晚期肺癌。早诊断早治疗，是延长肺癌患者生存时间最有效的手段。但通过低剂量螺旋CT发现的结节因为大小和位置，大部分难以在早期进行组织活检并完成病理分析。临床医生一直渴望能以精准、微创的介入手术来诊治肺癌、慢阻肺等肺部恶疾，由于肺部解剖结构和病灶位置等原因，病灶难以准确定位和精准到达，阻碍了介入手术在肺部疾病诊疗中的广泛应用。全肺病灶抵达的导航平台推出，是实现肺部疾病介入诊疗至关重要的技术突破。 堃博旗下的LungPro®系统是全球唯一实现全肺抵达的导航系统，拥有全球唯一经支气管出气道导航技术专利保护，该系统使临床医生第一次经气道入路在整个肺部实施介入手术，已获得美国FDA、欧洲CE以及中国NMPA认证，在全球范围内已经获得超过100 项专利授权。此外，InterVapor®热蒸汽治疗肺气肿系统、FleXNeedle®活检针、BioStar®一次性内窥镜吸引活检针、调可达™可调弯鞘管等介入耗材已经在不同国家和地区获批上市，射频消融治疗肺癌等项目也进入上市前临床试验阶段，为呼吸介入治疗带来全套解决方案。堃博CEO湛国威表示：「近年来，包括美敦力、强生、奥林巴斯等国际巨头在内的不同领域国际器械企业在肺部领域深度布局，验证了Broncus领先于市场在介入呼吸领域发力的前瞻视野，来自业界顶尖企业、医生、投资者的认可和支持也夯实了堃博的先锋地位。对比其他产品而言，LungPoint®和LungPro®系统优势明显，堃博以全肺导航为平台，正进一步加速微创、精准的介入诊治技术的开发和商业化应用，不断为医生和患者提供各种肺部恶疾的创新诊治方案。」本轮领投方清池资本创始人李彬博士表示：「堃博是清池资本今年在医疗器械领域的又一重大投资布局。在全球范围内，肺部疾病的介入诊疗存在着巨大的医学缺口。堃博拥有全球领...